August 5, 2019 09:59 AM EDT
Deals

Take­da kicks up GPCR work with So­sei Hep­tares, dish­ing out $26M to get GI drug dis­cov­ery go­ing

Amber Tong

Take­da is join­ing the grow­ing group of big-league play­ers en­list­ing the GPCR ex­perts at So­sei Hep­tares for drug de­sign work.

Much like the

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

Trump blog: FDA, NIH picks clear Sen­ate pan­el; FDA top lawyer re­signs

Up­dat­ed: White House pulls Wel­don's nom­i­na­tion to lead CDC at last minute

MeiraGTx teams with cryp­tic AI start­up, co-found­ed by Er­ic Schmidt, to ad­vance Parkin­son's gene ther­a­py

Up­dat­ed: En­do and Mallinck­rodt to merge in $6.7B deal

The new CEO of GoodRx wants to lean in­to brand names and speed up the drug dis­count com­pa­ny's growth

sponsored

Obe­si­ty drug de­vel­op­ment—still room to grow

A service from the Financial Times